FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

771590007: Erenumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3706918013 Erenumab en Synonym Active Entire term case insensitive SNOMED CT core module
3706919017 Erenumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erenumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Erenumab Has disposition Calcitonin gene-related peptide receptor antagonist true Inferred relationship Existential restriction modifier
Erenumab Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing erenumab (medicinal product) Has active ingredient True Erenumab Inferred relationship Existential restriction modifier 1
Product containing erenumab in parenteral dose form (medicinal product form) Has active ingredient True Erenumab Inferred relationship Existential restriction modifier 1
Erenumab Has active ingredient True Erenumab Inferred relationship Existential restriction modifier 1
Product containing only erenumab in parenteral dose form (medicinal product form) Has active ingredient True Erenumab Inferred relationship Existential restriction modifier 1
Product containing precisely erenumab 70 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Erenumab Inferred relationship Existential restriction modifier 1
Product containing precisely erenumab 70 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Erenumab Inferred relationship Existential restriction modifier 1
Product containing precisely erenumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Erenumab Inferred relationship Existential restriction modifier 1
Product containing precisely erenumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Erenumab Inferred relationship Existential restriction modifier 1
Aimovig 140mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier
Erenumab 140mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier
Aimovig 140mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier
Erenumab 70mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier
Erenumab 70mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier
Erenumab 140mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier
Aimovig 70mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier
Aimovig 70mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Erenumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start